SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-081412
Filing Date
2023-10-30
Accepted
2023-10-30 08:00:17
Documents
16
Period of Report
2023-10-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea187440-6k_immuron.htm 6-K 13843
2 IMMURON CEO, STEVEN LYDEAMORE TO PRESENT AT AUSBIOINVEST ea187440ex99-1_immuron.htm EX-99.1 28231
3 GRAPHIC image_001.jpg GRAPHIC 2291
4 GRAPHIC ex99-1_001.jpg GRAPHIC 574202
5 GRAPHIC ex99-1_002.jpg GRAPHIC 843403
6 GRAPHIC ex99-1_003.jpg GRAPHIC 566031
7 GRAPHIC ex99-1_004.jpg GRAPHIC 921163
8 GRAPHIC ex99-1_005.jpg GRAPHIC 574232
9 GRAPHIC ex99-1_006.jpg GRAPHIC 1026882
10 GRAPHIC ex99-1_007.jpg GRAPHIC 976985
11 GRAPHIC ex99-1_008.jpg GRAPHIC 735851
12 GRAPHIC ex99-1_009.jpg GRAPHIC 408006
13 GRAPHIC ex99-1_010.jpg GRAPHIC 1333987
14 GRAPHIC ex99-1_011.jpg GRAPHIC 17461
15 GRAPHIC ex99-1_012.jpg GRAPHIC 21041
16 GRAPHIC ex99-1_013.jpg GRAPHIC 10372
  Complete submission text file 0001213900-23-081412.txt   11078737
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 231357257
SIC: 2834 Pharmaceutical Preparations